NewLimit
Conner Kummerlowe is a Senior Data Scientist at NewLimit since January 2023, previously serving as Data Scientist II. Prior to this role, Kummerlowe conducted postdoctoral research in computational biology and data science at the Massachusetts Institute of Technology from August 2017 to January 2023, where innovations included a model enhancing experimentation efficiency by 1000% and key discoveries in therapeutic development from high-dimensional data. Academic accomplishments include a PhD in Computational and Systems Biology from MIT, an MPhil in Computational Biology from the University of Cambridge, and a Bachelor's degree in Chemistry with a Mathematics minor from Pomona College. Earlier experience includes a bioinformatics software development internship at Genestack and undergraduate research presentations at Pomona College.
This person is not in the org chart
This person is not in any offices
NewLimit
NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.